MEA Micro Invasive Glaucoma Surgery (MIGS) Devices Market - Industry Trends and Forecast to 2029

MEA Micro Invasive Glaucoma Surgery (MIGS) Devices Market - Industry Trends and Forecast to 2029

The micro invasive glaucoma surgery (MIGS) devices market is projected to register a substantial CAGR of 33.3% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029.

Market Segmentation
Middle East and Africa Micro Invasive Glaucoma Surgery (MIGS) Devices Market, By Product (MIGS Stents, MIGS Shunts and Others), Target (Trabecular Meshwork Suprachoroidal Space Subconjunctival Filtration and Reducing Aqueous Production), Surgery Type (Glaucoma in Conjunction with Cataract and Stand-Alone Glaucoma), End User (Hospital Outpatient Departments (HOPD), Ophthalmology Clinics, Ambulatory Surgery Centers (ASCS) and Others), Distribution Channel (Direct Tender and Retail Sales), Country (South Africa, Saudi Arabia, U.A.E., Israel, Egypt and rest of Middle East and Africa) – Industry Trends & Forecast to 2029

Some of the major factors contributing to the growth of the global micro invasive glaucoma surgery (MIGS) devices market are:

• Increase in the geriatric population
• Rising incidence of glaucoma across the world
• Government initiatives to increase awareness about prevention of blindness

Market Players

The key market players for the micro invasive glaucoma surgery (MIGS) devices market are listed below:

• AbbVie
• BVI
• Ellex
• Glaukos Corporation
• Johnson and Johnson
• Alcon
• Microsurgical technology
• New World Medical
• Santen Pharmaceutical
• Nova Eye Medical Limited
• Belkin Vision
• Sight Scientific




Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.